金利華電(300069.SZ):籌劃出售江西強聯100%股權
格隆匯 4 月 6日丨金利華電(300069.SZ)公佈,為優化資產結構,着眼於長遠發展,公司籌劃出售全資子公司江西強聯電氣有限公司(以下簡稱"江西強聯")100%股權,目前已與交易對手方趙堅達成交易意向,此次交易的具體方案與價格待雙方進一步協商確定。江西強聯的主營業務是生產、銷售懸式瓷絕緣子、高強度棒形支柱瓷絕緣子、輕型棒形瓷絕緣子、複合絕緣子用瓷芯棒。
據悉,此次籌劃出售資產的交易對手方為趙堅,趙堅目前持有公司14.02%股權,對應的表決權、提案權等股東權利已全部不可撤銷地永久委託給公司控股股東山西紅太陽行使。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.